Inventor · disambiguated record
Yongping Xie
Also filed as: XIE YONGPING
24 granted patents·12 pending applications·209 citations·filing 2000–2022
96Inventor score
Top patents by PatentIndex Score
36 records- 0195US8501758B2Compounds and compositions as protein kinase inhibitorsHUANG SHENLIN·Filed 2010·Granted Aug 6, 2013·40 cites·12 claims
- 0292US9850230B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·7 cites·9 claims
- 0392US9593100B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·25 claims
- 0492US9593099B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·2 claims
- 0591US9850229B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·5 cites·20 claims
- 0691US8202876B2Compounds and compositions as protein kinase inhibitorsALBAUGH PAMELA·Filed 2007·Granted Jun 19, 2012·39 cites·9 claims
- 0789US9314464B2Compounds and compositions as protein kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Apr 19, 2016·7 cites·27 claims
- 0887US10005761B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 26, 2018·3 cites·28 claims
- 0987US8431607B2Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2007·Granted Apr 30, 2013·12 cites·8 claims
- 1086US7868018B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2006·Granted Jan 11, 2011·11 cites·10 claims
- 1186US7572811B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2005·Granted Aug 11, 2009·11 cites·13 claims
- 1284US6670373B1Compounds and method for inhibiting MRP1LILLY CO ELI·Filed 2000·Granted Dec 30, 2003·27 cites·27 claims
- 1382US2023116233A1Compounds And Compositions As Protein Kinase InhibitorsARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1481US10576080B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Mar 3, 2020·1 cites·22 claims
- 1581US10568884B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 25, 2020·1 cites·14 claims
- 1680USRE49556ECompounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Granted Jun 20, 2023·0 cites·15 claims
- 1780US7846923B2Compounds and compositions as protein kinase inhbitorsIRM LLC·Filed 2007·Granted Dec 7, 2010·5 cites·6 claims
- 1880US7449582B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Nov 11, 2008·15 cites·5 claims
- 1975US8026243B2[4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitorsNOVARTIS AG·Filed 2007·Granted Sep 27, 2011·2 cites·19 claims
- 2073US2020323852A1Compounds And Compositions As Protein Kinase InhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2171US6743794B2Methods and compounds for inhibiting MRP1LILLY CO ELI·Filed 2000·Granted Jun 1, 2004·7 cites·39 claims
- 2268US11384078B25,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2018·Granted Jul 12, 2022·1 cites·20 claims
- 2363US6605596B2Indolocarbazole anticancer agents and methods of using themADVANCED LIFE SCIENCES INC·Filed 2001·Granted Aug 12, 2003·1 cites·42 claims
- 2460US2022324863A15,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2549US2010184765A1Protein Kinase Inhibitors and Methods for Using ThereofIRM LLC·Filed 2008·Application pending·0 cites
- 2648US2011053932A1Protein Kinase Inhibitors and Methods for Using ThereofIRM LLC·Filed 2008·Application pending·0 cites
- 2748US2004077675A1Compounds and methods for inhibiting MRP1Filed 2003·Application pending·0 cites
- 2848US2013210769A1Compounds and compositions as inhibitors of cannabinoid receptor 1 activityLIU HONG·Filed 2013·Application pending·0 cites
- 2946US2009312321A1Compositions and methods for fgf receptor kinases inhibitorsIRM LLC·Filed 2007·Application pending·0 cites
- 3044US7750032B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2006·Granted Jul 6, 2010·0 cites·9 claims
- 3141US2008292608A1Compounds and Compositions as Ppar ModulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 3241US2009192203A1Compounds and compositions as ppar modulatorsIRM LLC·Filed 2006·Application pending·0 cites
- 3339US9181238B2N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitorsPAN SHIFENG·Filed 2011·Granted Nov 10, 2015·0 cites·11 claims
- 3438US7820705B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2005·Granted Oct 26, 2010·0 cites·7 claims
- 3538US2007244130A1Compounds and Compositions as Ppar ModulatorsIRM LLC·Filed 2005·Application pending·0 cites
- 3638US2007203155A1Compounds And Compositions As Ppar ModulatorsIRM LLC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yongping Xie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →